Removal of small viruses (parvovirus) from IgG solution by virus removal filter Planova®20N

Journal of Membrane Science

Volumn 278, Issue 1-2, 2006, Pages 3-9

  Hongo Hirasaki, Tomoko ^a   Yamaguchi, Kazuhito ^b   Yanagida, Kouichirou ^a   Okuyama, Kazuo ^a  

^a Asahi Kasei Medical Co   (Japan)

^b YAMAGUCHI UNIVERSITY   (Japan)

Author keywords

Membrane structure; Parvovirus; Protein filterability; Trapping capacity; Virus removal filter

Indexed keywords

CELLULOSE; FIBROUS MEMBRANES; FILTRATION; MATHEMATICAL MODELS; PROTEINS; SOLUTIONS;

MEMBRANE STRUCTURE; PARVOVIRUS; PROTEIN FILTERABILITY; TRAPPING CAPACITY; VIRUS REMOVAL FILTER;

VIRUSES;

CUPROPHANE; IMMUNOGLOBULIN G;

CELLULOSE; FIBROUS MEMBRANES; FILTRATION; MATHEMATICAL MODELS; PROTEINS; SOLUTIONS; VIRUSES;

ARTICLE; FILTRATION; MEMBRANE STRUCTURE; NONHUMAN; OUTCOME ASSESSMENT; PORCINE PARVOVIRUS; POROSITY; PRIORITY JOURNAL;

CELLULOSE; FILTRATION; MATHEMATICAL MODELS; MEMBRANES; PROTEINS; VIRUSES;

EID: 33646759901     PISSN: 03767388     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.memsci.2005.10.057     Document Type: Article

References (28)

1. Evatt B.L., Gomperts E.D., McDougal J.S., and Ramsey R.B. Coincidental appearance of LAV/HTLV-III antibodies in hemophiliacs and the onset of AIDS epidemic. New Engl. J. Med. 312 (1985) 483-486
2. Blemchet V.S., Vorstman E., Shore A., et al. Hepatitis C infection in children with hemophilia A and B. Blood 78 (1991) 285-289
3. Gerritzen A., Schneweis K.E., Brackmann H.-H., Oldenburg J., Nfland P., Gerlich W.H., and Caspari G. Acute hepatitis A in haemophiliacs. Lancet 340 (1992) 1231-1232
4. Yu M.W., Mason B.L., Guo Z.P., et al. Hepatitis C transmission associated with intravenous immunoglobulins. Lancet 345 8958 (1995) 1173-1174
5. Bartolomei Corsi O., Azzi A., Morfini M., Fanci R., and Rossi Ferrini P. Human parvovirus infection in hemophiliacs first infused with treated clotting factor concentrates. J. Med. Virol. 25 (1988) 151-153
6. Santagostino E., Mannucci P.M., Gringeri A., Azzi A., Morfini M., Musso R., Santoro R., and Schiavoni M. Transmission of parvovirus B19 by coagulation factor concentrates exposed to 100°C heat after lyophilization. Transfusion 37 5 (1997) 517-522
7. Blumel J., Schmidt I., Effenberger W., Seitz H., Willkommen H., Brackmann H.H., Lower J., and Eis-Hubinger A.M. Parvovirus B19 transmission by heat-treated clotting factor concentrates. Transfusion 42 (2002) 1473-1481
8. Peterson L.R., Satten G.A., Dodd R.Y., et al. Duration of time from onset of human immunodeficiency virus type 1 infectiousness to development of detectable antibody. Transfusion 34 (1994) 283-289
9. Wu C.G., Mason B., Jong J., Erdman D., McKernan L., Oakley M., Souice M., Evatt B., and Yu M.Y. Parvovirus B19 transmission by a high-purity factor concentrate. Transfusion 45 6 (2005) 1003-1010
10. CPMP/BWP/BPWG/4080/00, EMEA workshop on viral safety of plasma-derived medicinal products with particular focus on non-enveloped viruses.
11. Shoichi Ide, Takashi Tsurumi, Hiromi Nagashima, Japan Open Patent No. H4-371221 (1992).
12. Hirasaki T., Ishikawa G., Nakano H., Manabe S., and Yamamoto N. Mechanism of virus removal by regenerated cellulose hollow fiber (BMM™). Membrane 20 2 (1995) 135-142
13. CPMP/ICH/295/95, ICH Q5A, Quality of biotechnological products: viral safety evaluation of biotechnology products derived from cell lines of human or animal origin, 1997.
14. Shoichi Ide, Toshiaki Noda, WO-2001-14047.
15. Lutz H., Siwak M., and Carter J. Viral Clearance Performance and Regulatory Requirements (2002), Biophex/Interphex, CA, USA
16. Martin J. Case Study-Orthogonal Membrane Technologies for Viral and DNA Clearance (2005), Japan Society for Viral Safety Research on Biologics, Tokyo
17. Ishikawa G., Hirasaki T., Manabe S., and Yamamoto N. Novel determination method of size of virus in solution using cuprammonium regenerated cellulose membrane (BMM). Membrane 16 6 (1991) 376-386
18. Tomoko Hongo, Naoko Hamasaki, Shoichi Ide, Fumihiko Yamaguchi, Mitsunori Kubozaki, WO2005-007328.
19. K. Yanagida, unpublished data.
20. T.Hongo-Hirasaki, S.Ide. K. Okuyama, J. Membr. Sci., in preparation.
21. Yamaguchi K., Miyagawa E., Dan M., Miyazaki T., and Ikeda H. Cellulose hollow fibers (BMMs) used in the filter membrane can trap human parvovirus (B19). Proceedings of the 15th ICEM. Durban, South Africa (2002) 115-116 (abstract)
22. Tsurumi T., Sato T., Osawa N., Hitaka H., Hirasaki T., Yamaguchi K., Hamamoto Y., Manabe S., Yamashiki T., and Yamamoto N. Structure and filtration performances of improved cuprammonium regenerated cellulose hollow fiber (improved BMM hollow fiber) for virus removal. Polym. J. 22 12 (1990) 1085-1100
23. Tsurumi T., Osawa N., Hirasaki T., Yamaguchi K., Manabe S., and Yamashiki T. Mechanism of removing monodisperse gold particles from a suspension using cuprammonium regenerated cellulose hollow fiber (BMM hollow fiber). Polym. J. 22 4 (1990) 304-311
24. Manabe S., and Tsurumi T. Removal of viruses with a membrane filter. Artif. Kidney 17 4 (1988) 1497-1503
25. T. Tsurumi, Design for aggregation structure of polymeric porous membrane with virus removal ability, Dr. Thesis, 1990.
26. Yokogi M. Virus separation by cellulose hollow fiber membrane. SEN-I GAKKAISHI 55 10 (1999) 55-59
27. Cabatingan M. Preparation of Virus Stocks Impacts Viral Clearance Studies (2005), PDA Virus and TSE Safety, Bethesda
28. T.Hongo-Hirasaki, K. Yanagida, K. Okuyama, J. Membr. Sci., in preparation.